QURE Healthcare
San Francisco, California, 94109, United States
NCT Number: NCT02915653
The study is a pre-post two round, randomized controlled study design of PCPs randomly assigned to a control or 1 of 2 intervention arms.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
San Francisco, California, 94109, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Educational materials on a new diagnostic service
Time frame: 8 weeks
Difference in difference of combined diagnostic and treatment CPV domain scores, including colonoscopy referral rates, in post-intervention versus baseline comparing intervention and control groups among the three patient types.
Time frame: 8 weeks
Difference in difference between the control and intervention groups in the overall quality of care for CRC screening and for adult primary prevention care measured by the combined and individual item CPV scores for the three patient types.
Time frame: 8 weeks
Difference in health care utilization and/or costs in patients tested with SimpliPro Colon™ versus the control group.
Time frame: 8 weeks
Difference in recommendation of CRC evaluation with colonoscopy and/or flexible sigmoidoscopy, double barium enema, or CT colonography, including risk-level and urgency pre- and post-intervention, between intervention and control groups
Qure Healthcare, LLC
Industry
Acronym: APPP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06184386
Preventive Care
Caen, Normandy, France
View Trial DetailsNCT04847856
Diabetes Mellitus, Diabetes Mellitus, Type 2
Tabuk, Saudi Arabia
View Trial DetailsNCT03091036
Bronchial Diseases, Bronchiolitis
Madrid, Spain
View Trial DetailsNCT00581347
Adolescent Immunizations, Preventive Care
Rochester, New York, United States
View Trial Details